Aurora Cannabis Welcomes Kerry Miller as New Managing Director for ANZ Operations

Aurora Cannabis Welcomes New Leadership in Australia and New Zealand

Aurora Cannabis Inc., a prominent player in the global medical cannabis industry, has recently appointed Kerry Miller as the Managing Director for Australia and New Zealand, effective January 15, 2026. This strategic move is anticipated to accelerate the company’s growth and innovation in these pivotal markets.

Kerry Miller brings over 35 years of extensive experience in the consumer packaged goods sector, with a substantial portion of his career spent in leadership positions at major companies including Reckitt Benckiser and Unilever. His wealth of knowledge in navigating fast-paced and regulated industries positions him well to lead Aurora's operations in Australia and New Zealand.

In a statement reflecting his enthusiasm about the new role, Miller expressed, "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated to expanding access to medical cannabis. I look forward to accelerating innovation, strengthening partnerships, and delivering meaningful value to patients and stakeholders across Australia and New Zealand."

Throughout his career, Miller has been known for driving significant growth and transformation across various global markets including the USA, UK, and several countries in Africa and Asia. His expertise in leading teams to achieve remarkable topline growth and enhancing market share will be invaluable as Aurora aims to expand its footprint in Australia and New Zealand.

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alberta, Aurora is a pioneering force in the global cannabis market. The company's vast portfolio caters to both medical and consumer markets, with brands such as Drift, San Rafael '71, and MedReleaf. As a company committed to quality and innovation, Aurora continuously strives to enhance the lives of its customers through its comprehensive range of cannabis products.

In addition to its core offerings in Canada and Europe, Aurora is delving deeper into the Australia and New Zealand markets, aiming to provide accessible and effective medical cannabis solutions. The leadership of Kerry Miller is seen as a critical component in achieving this goal, driving rigorous efforts to raise awareness and establish a robust presence in these regions.

As Aurora navigates this crucial phase, the company is optimistic about its potential growth, backed by Miller's expertise in fostering key strategic partnerships and enhancing the overall consumer experience.

With ongoing transformations in the cannabis industry and its acceptance in various regions, Aurora is ideally positioned to lead in both markets. By leveraging Miller’s development tracks, Aurora aims not just to meet the existing demands but to innovate and provide unparalleled service to medical cannabis patients in Australia and New Zealand.

The company is also committed to addressing the evolving landscape of market regulations in Australia and New Zealand, understanding the complexities involved in operating within these jurisdictions. This commitment underscores Aurora’s goal of maintaining operational excellence while adhering to the highest standards of compliance and consumer trust.

As Aurora Cannabis makes strides under the direction of Kerry Miller, stakeholders and patients in Australia and New Zealand can anticipate a future marked by substantial advancements in medical cannabis access and application. The forthcoming period promises significant growth opportunities aimed at enhancing the quality of life for individuals relying on medical cannabis solutions.

In conclusion, the appointment of Kerry Miller marks a progressive step for Aurora Cannabis as it seeks to more effectively serve the Australian and New Zealand markets. With a focus on innovation, compliance, and patient-centered services, the company is set to elevate its contributions to the global cannabis landscape.